3
1

LDL and Heart Disease: Oxidized vs. Native Particles - Chris Masterjohn PhD [Interview]

6d 5h ago by hackertalks.com/u/jet in carnivore@discuss.online from youtu.be

how much does mitochondrial energy metabolism shape long-term health outcomes — and what does that mean for how we interpret cardiovascular, immune, and metabolic research? Dave sits down with Chris Masterjohn (PhD) to explore his mitochondrial testing company and what enzyme-complex patterns may reveal about individual nutritional needs, his longstanding model of LDL oxidation and plaque formation, the emerging pressure-based hypothesis in Crohn's disease research, concerns he raises about polyunsaturated fatty acids and long-term trial design, and the state of peer review and research transparency.

summerizer

Mitochondrial testing and nutrition

  • Chris Masterjohn uses cheek-swab mitochondrial testing to evaluate enzyme-complex patterns, ATP production, and ratios that can point toward nutrient and diet protocols.
  • The goal is a pattern that maps onto methylation status, B-vitamin needs, MTHFR-related protein tolerance, carbohydrate tolerance, riboflavin, CoQ10, and similar levers.
  • Mitochondria matter because every active cellular process needs energy, including LDL receptor work, cholesterol movement, motor proteins, chaperones, caveolae, synthesis, maintenance, repair, and distribution.
  • When cellular energy is impaired, the body can lose normal active control over lipid handling, immune function, tissue repair, and basic cellular order.

Mitochondrial interventions, dose response, and outliers

  • Most health optimization is not a quick miracle, because many outcomes need years of consistent work and measurable biological change.
  • Individual patterns can still produce dramatic results; one woman had no period for ten years, her test pointed to 7,800 mg CoQ10, and her period returned within two weeks and persisted.
  • CoQ10 randomized trials usually show modest benefits near 100–200 mg/day for glucose and blood pressure, while dose-response analyses often look worse at higher average doses.
  • The case does not make high-dose CoQ10 a universal answer; it shows why individual mitochondrial bottlenecks may differ from group averages.

Exercise, biomechanics, and longevity

  • Exercise science has deep knowledge for elite performance, but average-person health guidance still barely moves beyond cardio plus a few resistance-training days.
  • A large international-athlete longevity study showed cyclists and runners about two to three extra years, while pole vaulters and gymnasts showed about eight extra years.
  • Cardiorespiratory fitness matters, but it cannot explain the whole longevity spread across sports.
  • Pole vaulters and gymnasts may share exceptional joints, tissue quality, spatial control, balance, coordination, and biomechanical resilience.
  • Hard landings alone do not explain the pattern, because volleyball was worse and martial arts did not show the same longevity benefit.
  • Biomechanics may connect to cancer, neurodegeneration, inflammation, and immune surveillance through extracellular matrix mechanics, not only to falls and orthopedic injury.

Extracellular matrix, immunity, and Crohn's disease

  • T-cell activation depends partly on whether cells can push and pull against extracellular matrix, so tissue mechanics may regulate adaptive immunity.
  • Cancer may exploit extracellular-matrix mechanics to block T-cell activation, while inflammatory disease may involve the opposite pressure pattern.
  • Crohn's disease looks like a pressure and biomechanics problem layered on genetics, metabolism, food texture, and segment-specific intestinal mechanics.
  • Liquid diets can help Crohn's because they reduce physical pressure from ordinary food moving through vulnerable bowel segments.
  • A Crohn's genetic cue was linked to a pressure-receptor gene in the transcript, and altitude above 5,000 feet was linked to flare risk through lower external pressure.
  • In a hypobaric-chamber experiment, three hours of low-pressure exposure led to flares in about one-third of participants in the transcript's account.
  • Breastfeeding for more than six months was contrasted with less than six months and linked to much lower Crohn's incidence.
  • Modern Crohn's may depend on modern food environments, reduced breastfeeding duration, altered development, and biomechanical vulnerability.

Ancestral health, agriculture, and uncertainty

  • Paleo and ancestral-health work overlaps with Weston Price ideas, but human diet history does not reduce to simple grain rejection.
  • The largest dietary break may be the industrial revolution, not necessarily the agricultural revolution.
  • Archaeological remains have selection bias, and early agriculture may show a temporary health decline followed by adaptation and regression toward prior averages.
  • Wheat-heavy diets can fail when they lack protein, minerals, and food-processing context, but humans also developed preparation methods and dietary pairings around grains.
  • Ancestral reasoning is useful only when speculation is identified and separated from what the evidence can directly show.

Causal inference, language, and peer review

  • Nutrition science needs explicit causal inference, not a fear of causal language even after randomized trials.
  • Bayesian reasoning helps because people already work from prior probabilities, mechanisms, and new evidence whether they admit it or not.
  • The Stanford identical-twin vegan trial was used as an example of exploratory data written with language that can sound stronger than the design supports.
  • Journals often lack dedicated reviewers for statistics, causal inference, and study-language calibration.
  • Transparent peer review, signed reviews, and published reviewer comments could improve accountability, though retaliation and reviewer incentives remain problems.
  • Peer review needs structure that rewards careful review work without invisible uncompensated labor.

LDL, oxidation, aggregation, and atherosclerosis

  • Native undamaged LDL is not the direct driver in Masterjohn's model; damaged or modified LDL becomes dangerous when lipid peroxidation damages apoB and promotes macrophage uptake.
  • Plaque works as a containment zone for toxic lipid-peroxidation products, not merely as passive cholesterol storage.
  • LDL aggregation can contribute to macrophage uptake, but aggregation still fits a broader damage-and-retention model.
  • LDL concentration by itself is not enough; particle damage, oxidation susceptibility, immune context, and endothelial handling all matter.
  • Most heart attacks and strokes come from plaque rupture or degradation, while stable macrocalcification on a calcium scan differs from dangerous microcalcification in the fibrous cap.
  • LDL entry into the artery wall is not passive smashing through an inert barrier; endothelial permeability, shear stress, inflammation, caveolae, SRB1, and transcytosis regulate movement.
  • Branch points with disturbed flow are more atherosclerosis-prone, and animal work with gold nanoparticles was used to illustrate size-permeability behavior.
  • ApoB lipoproteins also function in innate immunity and host defense, including transport of vitamin E and protection against oxidative stress in vulnerable spaces.
  • Vitamin E is not only lipoprotein decoration; it is antioxidant cargo that can move through lipoproteins, tissues, and the blood-brain barrier.

Familial hypercholesterolemia and LDL causality

  • Familial hypercholesterolemia is often used as a proxy for LDL causality, but monogenic FH differs from polygenic high LDL at the same LDL concentration.
  • LDLR, APOB, PCSK9 gain-of-function, and LDLRAP defects can alter receptor biology, immune behavior, and macrophage function beyond measured LDL concentration.
  • Homozygous FH and heterozygous FH show different timing and severity, and Brown-Goldstein cases show what extreme receptor loss can do early in life.
  • Statins may reduce oxidation risk partly by clearing LDL faster, not only by lowering the measured LDL number.
  • A 2020 EAS consensus paper was used because it includes LDL movement across endothelium, but the mechanism still includes regulated immune and endothelial processes.
  • Monocytes, macrophages, oxidized LDL, and native LDL move through a dynamic subendothelial space without a static trap.

Lean Mass Hyper-Responders and coronary CT angiography

  • The Lean Mass Hyper-Responder work is central because very high LDL and ApoB in carbohydrate-restricted people creates a direct stress test for lipid-causality models.
  • The Keto CTA study and newer plaque-progression analyses used CCTA methods including semi-quantitative review, QAngio, and HeartFlow.
  • The current analyses kept the original thesis: baseline plaque predicted future plaque progression, while LDL and ApoB did not show an association with progression in this dataset.
  • Very small R² values around 0.01–0.015 were given for LDL/ApoB and plaque progression.
  • Plaque regression occurred in some people, and baseline plaque was necessary before regression could be measured.
  • The study became a case example for how scientific data, public interpretation, prerelease analysis, and institutional trust can collide.

Seed oils, dose, and oxidative liability

  • Seed oils are not equally dangerous in every dose; a little soy or canola oil in salad dressing is different from using seed oil as a daily base fat.
  • The core problem is oxidative liability: higher linoleic acid in membranes and lipoproteins creates a glass-house environment when oxidative stress rises.
  • PUFA does not have to cause oxidative stress to matter; it can magnify damage once mitochondrial decline, aging, inflammation, or toxin exposure creates oxidant pressure.
  • Short seed-oil trials can look favorable, especially when they lower LDL or liver fat, while long-term outcomes may move in a different direction.
  • Many nutrition and drug interventions look better over eight to twelve weeks than over years, and SSRIs were used as an analogy for short trial windows versus long clinical use.
  • Funding incentives favor short, novel, non-threatening studies over long trials that could overturn profitable or institutional commitments.

Seed-oil trials and long-term outcomes

  • The LA Veterans Administration Hospital trial was the longest seed-oil trial in the transcript, lasted eight years, and concluded that even eight years was not long enough.
  • Cancer increases in the seed-oil group emerged mainly after the first two years and especially around years five to seven.
  • The Minnesota Coronary Survey and LA Veterans trial were identified as the two long, large, double-blind randomized seed-oil trials.
  • Taken together, those trials were summarized as probably unfavorable for heart disease and cancer, despite complexities in total mortality and timing.
  • Modern seven-to-twelve-week trials cannot answer the same long-latency questions.
  • Observational seed-oil studies after public health campaigns are highly vulnerable to health-user bias.

Seed oils, LDL lowering, liver fat, and oxidation

  • Seed oils can lower LDL by increasing LDL receptor activity and faster clearance, while also enriching LDL with more oxidation-prone fatty acids.
  • Liver PUFA metabolism may lower liver fat and increase ketones, so short-term metabolic markers can improve while long-term oxidative risk rises.
  • Daniel Steinberg's oxidized-LDL work was used as the historical bridge between cholesterol lowering and seed-oil concern.
  • The smoking-gun idea was that dietary fat composition changes LDL oxidizability, and corn-oil-enriched LDL can become more vulnerable to oxidation.
  • This creates a tradeoff: the same intervention can improve one pathway while worsening another.

Research design, regression to the mean, and trial interpretation

  • Event-driven trials can stop after statistical significance and accidentally preserve an unusually favorable early result.
  • Regression to the mean matters when people are selected for high cholesterol, because repeated testing tends to move extreme values closer to the average.
  • Within-person cholesterol variation was given as roughly 17 mg/dL over repeated measures across a year.
  • Large first-study effects often shrink when later studies are larger, longer, or less lucky.
  • Subgroup analyses are usually unreliable, and giant pharma or device trials are rarely replicated at the same scale.
  • FOURIER was used as an example where cardiovascular endpoints improved but deaths were numerically higher in the intervention arm without statistical significance.

Research incentives, open data, and institutional reform

  • NIH and academic funding systems are constrained by bureaucracy, congressional allocations, career incentives, and institutional inertia.
  • Research agendas do not reliably rank the most important unanswered questions across nutrition and medicine.
  • Crowdfunded and decentralized research could move faster, but academic careers still depend on papers, journals, H-index incentives, and control of datasets.
  • Taxpayer-funded data should be public, including NIH and CDC datasets, so independent analysts can check work rapidly.
  • AI plus open code and open data could make errors visible quickly and reduce dependence on opaque institutional gatekeeping.
  • Systematic review teams need content expertise, statistics, causal inference, and history of the field, without pharmaceutical or institutional capture.

Personal diet, supplements, and genetics

  • Masterjohn's diet includes beef, organs, rice, nixtamalized corn tortillas, egg yolks, potatoes, tomatoes, peppers, broccoli, olive oil, cheese, heavy cream, and strawberries.
  • His rough intake is about 150 g net carbohydrate, 160 g protein, the rest fat, and around 2,805 kcal.
  • His supplements include creatine, molybdenum, vitamin K2, CoQ10, food-based vitamin C, and one autocaption-unclear item.
  • Whole-genome sequencing is preferred over SNP chips when investigating COMT and other genetic findings, because genome-wide context matters.

References

:::

This talk is a doozy, they GET INTO THE WEEDS on LDL mechanistic theories. Super interesting.